Active Ingredient History

NOW
  • Now
Ethosuximide is a succinimide anticonvulsant, used in the treatment of epilepsy. Ethosuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of epileptiform attacks is reduced, apparently by depression of the motor cortex and elevation of the threshold of the central nervous system to convulsive stimuli. Binds to T-type voltage sensitive calcium channels. Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1G gives rise to T-type calcium currents. T-type calcium channels belong to the "low-voltage activated (LVA)" group and are strongly blocked by mibefradil. A particularity of this type of channels is an opening at quite negative potentials and a voltage-dependent inactivation. T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle. They may also be involved in the modulation of firing patterns of neurons which is important for information processing as well as in cell growth processes. Ethosuximide is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.   NCATS

  • SMILES: CCC1(C)CC(=O)NC1=O
  • InChIKey: HAPOVYFOVVWLRS-UHFFFAOYSA-N
  • Mol. Mass: 141.1677
  • ALogP: 0.45
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$0.0662 - $3.6988

Australia

$1.0627 - $46.9754
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(+-)-2-ethyl-2-methylsuccinimide | (±)-2-ethyl-2-methylsuccinimide | 2-ethyl-2-methylsuccinimide | 2-methyl-2-ethylsuccinimide | 3-ethyl-3-methyl-2,5-pyrrolidinedione | 3-ethyl-3-methylsuccinimide | 3-methyl-3-ethylpyrrolidine-2,5-dione | 3-methyl-3-ethylsuccinimide | aethosuximide | alpha-ethyl-alpha-methylsuccinimide | alpha-methyl-alpha-ethylsuccinimide | atysmal | ci-366 | cn-10395 | emeside | ethosuxide | ethosuximid | ethosuximide | ethosuximidum | etosuximid | etosuximida | gamma-ethyl-gamma-methyl-succinimide | gamma-methyl-gamma-ethyl-succinimide | pm-671 | suxinutin | thilopemal | zarontin | γ-ethyl-γ-methyl-succinimide

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue